【Know·Chen】Dongchen Pharmaceutical is not just an MCC manufacturer!

Dongchen Pharmaceutical's software and hardware strength

①Company team

At present, the company has 35 employees, including 3 with master's degree and 13 with bachelor's degr.

Dongchen Pharmaceutical has established its own sales force, and at the same time authorized part of the domestic market to the parent company Shenzhen Youpuhui Pharmaceutical .

②Company R&D capability

Dongchen Pharmaceutical has a research and development laboratory, which can independently conduct research and development of pharmaceutical excipients, customized products, and other new materials:

TableClassification of Dongchen Pharmaceutical R&D Activities

Dongchen Pharmaceutical has established a preparation application research laborato.

The research level of Dongchen Pharmaceutical's microcrystalline cellulose has been recognized by the Hunan Institute of Drug Control, and participated in the revision of the 2020 version of the Chinese Pharmacopoeia microcrystalline cellulose quality standard hosted by the institu.

In addition, Dongchen Pharmaceutical also participated in the research work on the microcrystalline cellulose pellet core standard organized by the Guangdong Provincial Institute for Drug Contr.

③The company's production and testing capabilities

Dongchen Pharmaceutical has production workshops and production equipment built in accordance with GMP requirements, including a Class D clean production workshop of more than 1,000 square meters, a general production area of ​​more than 4,000 square meters, and an annual production capacity of 3,000 to.

Dongchen Pharmaceutical has established a testing center in line with product quality resear.

FigureSome instruments and equipment of Dongchen Pharmaceutical

Dongchen Pharmaceutical Qualification and Honor

• December 2021: Microcrystalline cellulose was activated under CDE registration number F20180000805 for use in pharmaceutical producti.

  
  

• November 2021: Microcrystalline cellulose colloidal silica co-processed product obtained CDE registration number F2021000040

• February 2021: Microcrystalline cellulose pellets were awarded CDE registration number F2021000005

• December 2020: New registration number F20200000586 for microcrystalline cellulo.

  
  

• December 2020: Dongchen Pharmaceutical was awarded the national high-tech enterprise certifica.

  
  

• June 2019: Dongchen Pharmaceutical was awarded the title of "Contract-honoring and Promise-keeping" Enterprise in Guangdong Province in 201

• February 2019: Dongchen Pharmaceutical obtained the ISO9001:2015 quality management system certificati.

  
  

• December 2018: Dongchen Pharmaceutical's microcrystalline cellulose, modified cellulose (microcrystalline cellulose-carboxymethylcellulose sodium), nanocrystalline cellulose and other products passed the certification of high-tech products in Guangdong Provin.

  
  

• November 2018: Dongchen Pharmaceutical won the New Materials Industry Excellence Award in the Growth Enterprise Group of the 6th "Pearl River Angel Cup" Science and Technology Innovation Competiti.

  
  

• October 2018: Dongchen Pharmaceutical won the 2018 Zhuhai "Science and Technology Cup" Innovation Competition Growth Group Excellence Awa.

  
  

• October 2018: Dongchen Pharmaceutical's microcrystalline cellulose obtained the CDE registration number F2018000080

• September 2018: Dongchen Pharmaceutical obtained the "Food Production Licens.

  
  

• April 2018: Dongchen Pharmaceutical's microcrystalline cellulose was filed with the FDA, DMF 03275

• December 2017: Dongchen Pharmaceutical changed its current name to "Zhuhai Dongchen Pharmaceutical .

  
  

• September 2017: Dongchen Pharmaceutical obtained the "Drug Production Licens.
  
  

• March 2012: Zhuhai Dongchen Pharmaceutical Technology .
  
  , L.
  
  was establish.